Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes.
about
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.
P2860
Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Effects of dipeptidyl peptidas ...... xic injury in type 2 diabetes.
@en
Effects of dipeptidyl peptidase-4
@nl
type
label
Effects of dipeptidyl peptidas ...... xic injury in type 2 diabetes.
@en
Effects of dipeptidyl peptidase-4
@nl
prefLabel
Effects of dipeptidyl peptidas ...... xic injury in type 2 diabetes.
@en
Effects of dipeptidyl peptidase-4
@nl
P2093
P1433
P1476
Effects of dipeptidyl peptidas ...... oxic injury in type 2 diabetes
@en
P2093
Ada De Luigi
Alessandro Corbelli
Chiara Chiabrando
Fabio Fiordaliso
Giovanna Balconi
Luigi Cervo
Roberto Latini
Serena Maggioni
Serge Masson
Xenia Antoniou
P356
10.1016/J.LFS.2016.03.052
P407
P577
2016-03-31T00:00:00Z